Growth Metrics

Cytosorbents (CTSO) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn 2.13%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.13%
Dec 31, 2025 -134.68%
Sep 30, 2025 118.39%
Jun 30, 2025 -10.94%
Mar 31, 2025 63.00%
Dec 31, 2024 8.77%
Sep 30, 2024 -16.02%
Jun 30, 2024 -184.81%
Mar 31, 2024 81.40%
Dec 31, 2023 34.04%
Sep 30, 2023 64.03%
Jun 30, 2023 102.99%
Mar 31, 2023 19.47%
Dec 31, 2022 87.68%
Sep 30, 2022 29.58%
Jun 30, 2022 -375.79%
Mar 31, 2022 -39.85%
Dec 31, 2021 -528.53%
Sep 30, 2021 -151.75%
Jun 30, 2021 -97.98%
Mar 31, 2021 -19.23%
Dec 31, 2020 34.00%
Sep 30, 2020 -28.16%
Jun 30, 2020 -51.96%
Mar 31, 2020 -7.24%
Dec 31, 2019 -24.67%
Sep 30, 2019 -14.18%
Jun 30, 2019 27.00%
Mar 31, 2019 -0.41%
Dec 31, 2018 44.42%
Sep 30, 2018 48.77%
Jun 30, 2018 -27.19%
Mar 31, 2018 -130.99%
Dec 31, 2017 -492.82%
Sep 30, 2017 -964.35%
Jun 30, 2017 -117.30%
Mar 31, 2017 49.51%
Dec 31, 2016 79.03%
Sep 30, 2016 -94.11%
Jun 30, 2016 687.45%
Mar 31, 2016 64.31%
Dec 31, 2015 -108.98%
Sep 30, 2015 139.73%
Jun 30, 2015 -282.84%
Mar 31, 2015 76.22%
Dec 31, 2014 3,275.26%
Sep 30, 2014 -15,743.73%
Jun 30, 2014 -173.40%
Mar 31, 2014 -218,148.44%
Dec 31, 2013 -820.05%
Sep 30, 2013 -432.06%
Jun 30, 2013 -124.75%
Mar 31, 2013 80.62%
Dec 31, 2012 -3,110.25%
Sep 30, 2012 121.52%
Dec 31, 2011 99.61%
Sep 30, 2011 -212.77%